J66213 Roxithromycin, 97%
SDS
| Größe | Preis ($) | Menge | Verfügbarkeit |
|---|---|---|---|
| 5g | 61,20 |
|
|
| 10g | 104,00 |
|
|
Roxithromycin, 97%
Chemische Eigenschaften
Anwendungen
Used to block bacterial protein synthesis. Clinically, used to treat respiratory tract, urinary and soft tissue infections.
Bemerkungen
Literaturverweise
Craig Knox et. al. DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Research, 2011,39D1035-D1041.
R N Jones; A L Barry; C Thornsberry. In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugs. Antimicrobial Agents and Chemotherapy, 1983,24(2), 209-215.
GHS Gefahren- und Sicherheitshinweise
Gefahrenhinweise (EU): H302
Harmful if swallowed.
Sicherheitshinweise: P260-P201-P280-P304+P340-P405-P501a
Do not breathe dust/fume/gas/mist/vapours/spray. Obtain special instructions before use. Wear protective gloves/protective clothing/eye protection/face protection. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.
Weitere Referenzen
Chemikalien
Life science
Metalle und Stoffe
Katalysatoren
